Key Account Manager

Pacific Southwest
- Los Angeles, Denver, Phoenix, Las Vegas

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients.

For more information, visit

Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization.

Position: Key Account Manager

Company: Azurity Pharmaceuticals

Location: Pacific Southwest
- Los Angeles, Denver, Phoenix, Las Vegas

Azurity Pharmaceuticals is a midsize, specialty pharmaceutical company dedicated to providing innovative and high-quality medicines that meet the unique needs of patients. We are driven by a commitment to access, innovation, and patient-focused solutions.

The Key Account Manager (KAM) will be a pivotal, field-based commercial leader responsible for developing and managing strategies to maximize utilization of Azurity’s diverse portfolio of innovative medicines within assigned Integrated Delivery Networks and large Health Systems. This role requires a sophisticated understanding of the evolving healthcare landscape, with a particular emphasis on building strategic relationships to identify unmet needs within the four key therapeutic areas
: Anti-infective, Gastroenterology, Respiratory, and Oncology
. The KAM will drive strategic engagement with high-level IDN decision makers to co‑create long-term value that aligns to Azurity’s commitment to providing high-quality, user-friendly formulations for overlooked patients.

Portfolio Access Strategy & Execution (60%)

• Develop and execute comprehensive IDN Account Business Plans that meet both company and customer objectives, focusing on growth, market access, and integration of Azurity’s multi-therapeutic portfolio (Anti-infective, Gastroenterology, Respiratory, and Oncology).
• Develop and sustain customer stakeholder maps that align both internal and external teams to the current strategy as well as future growth opportunities.
• Engage in economic discussions and negotiations with health systems, helping clients understand the value proposition and financial impact.
• Needs assessment and solutions: Understand client needs and challenges to develop and present tailored solutions and customized services.
• Conduct in-depth analysis of IDN performance data, utilization trends, and barriers to develop targeted pull-through strategies.
• Clearly articulate the unique clinical and economic value proposition of Azurity’s specialized dosage forms (e.g., oral solutions, suspensions, unique delivery systems) to IDN C-suite and D-suite stakeholders.

Key Stakeholder Engagement & Relationship Management (25%)

• Establish and maintain strong, strategic relationships with key IDN stakeholders at each level to ensure long-term sustainable growth of Azurity’s portfolio.
• Facilitate clinical pull-through of system strategy by partnering with Azurity's Field Sales team, market access, and medical affairs to educate providers on patient formulary status and patient clinical benefits across targeted therapeutic areas.
• Serve as the voice of the IDN customer internally, providing actionable market intelligence to inform internal strategies, launch planning, and future growth opportunities.

Internal Collaboration (15%)

• Work cross-functionally with Market Access/Strategic Accounts, Commercial Sales,…